It is Azura’s belief that AZR-MD-001 can reverse the core pathophysiology of these conditions, alleviating their signs and symptoms.
Our additional areas of focus include the development of our novel New Chemical Entities which target the pathophysiology of ocular surface diseases with a multi-modal mechanism of action.
Role of Keratolytics in Ophthalmology
Abnormal keratin production, deposition, and aggregation of keratin via disulfide bonds are the central problem in many ophthalmic conditions including Meibomian Gland Dysfunction, Contact Lens Discomfort, and blepharitis. 1, 2, 3